Jang M(1), Park R(1), Park YI(1), Cha YE(1), Yamamoto A(1), Lee JI(1), Park J(2). Author information:
(1)Division of Biological Science and Technology, Yonsei University, Wonju,
Republic of Korea.
(2)Division of Biological Science and Technology, Yonsei University, Wonju,
Republic of Korea. Electronic address: [Email]
COVID-19 pandemic results in record high deaths in many countries. Although a vaccine for SARS-CoV-2 is now available, effective antiviral drugs to treat coronavirus diseases are not available yet. Recently, EGCG, a green tea polyphenol, was reported to inhibit SARS-CoV-2 3CL-protease, however the effect of EGCG on coronavirus replication is unknown. In this report, human coronavirus HCoV-OC43 (beta coronavirus) and HCoV-229E (alpha coronavirus) were used to examine the effect of EGCG on coronavirus. EGCG treatment decreases 3CL-protease activity of HCoV-OC43 and HCoV-229E. Moreover, EGCG treatment decreased HCoV-OC43-induced cytotoxicity. Finally, we found that EGCG treatment decreased the levels of coronavirus RNA and protein in infected cell media. These results indicate that EGCG inhibits coronavirus replication.
Having over 250 Research scholars worldwide and more than 400 articles online with open access.